150 related articles for article (PubMed ID: 30632818)
1. Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Lou D; Cui X; Bao SS; Sun W; Pan WH; Chen MC; Dong YY; Hu GX; Chen RJ; Wang Z
Drug Dev Ind Pharm; 2019 Apr; 45(4):689-693. PubMed ID: 30632818
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Lin G; Wang C; Qiu X; Wang Z; Han A; Xu T; Kan X; Hu G
Drug Dev Ind Pharm; 2014 Dec; 40(12):1616-22. PubMed ID: 24053419
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Chen M; Zhang X; Chen Y; Sun W; Wang Z; Huang C; Hu G; Chen R
Xenobiotica; 2020 Mar; 50(3):280-287. PubMed ID: 31199171
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats.
Wang L; Wang S; Chen M; Chen X; Lin Y; Hu X; Huang X; Li X; Hu G
Drug Dev Ind Pharm; 2015; 41(10):1661-6. PubMed ID: 25417773
[TBL] [Abstract][Full Text] [Related]
5. Effects of CYP3A inhibitors ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of sunitinib and its main metabolite in rats.
Wang J; Cui X; Cheng C; Wang Y; Sun W; Huang CK; Chen RJ; Wang Z
Chem Biol Interact; 2021 Apr; 338():109426. PubMed ID: 33617800
[TBL] [Abstract][Full Text] [Related]
6. Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Gupta A; Unadkat JD; Mao Q
J Pharm Sci; 2007 Dec; 96(12):3226-35. PubMed ID: 17518356
[TBL] [Abstract][Full Text] [Related]
7. Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Luo X; Xue X; Li T; Zhang Y; Huang L; Cheng G
Curr Drug Metab; 2020; 21(13):1022-1030. PubMed ID: 33092505
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.
Shen L; Wang J; Yi Y; Ye C; Wang R; Xia G; Yu C; Tu F; Xu J; Zheng Z
Drug Test Anal; 2019 Apr; 11(4):595-600. PubMed ID: 30370647
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
Cai T; Liao Y; Chen Z; Zhu Y; Qiu X
Ann Pharmacother; 2020 Jul; 54(7):676-683. PubMed ID: 31893943
[No Abstract] [Full Text] [Related]
10. Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma.
Ye Z; Wang C; Li R; Chen C; Yang J; Chen Y; Fu J; Zhou T; Jin M; Huang A; Zhang X; Zhou Z
J Pharm Pharmacol; 2024 Jan; 76(2):115-121. PubMed ID: 38150242
[TBL] [Abstract][Full Text] [Related]
11. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats.
Lou Y; Song F; Cheng M; Hu Y; Chai Y; Hu Q; Wang Q; Zhou H; Bao M; Gu J; Zhang Y
PeerJ; 2023; 11():e15844. PubMed ID: 37581117
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of voriconazole, itraconazole and fluconazole on the pharmacokinetic profiles of ivosidenib in rats by UHPLC-MS/MS.
Xie S; Ye L; Ye X; Lin G; Xu RA
J Pharm Biomed Anal; 2020 Aug; 187():113353. PubMed ID: 32417565
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Greenblatt DJ; von Moltke LL; Harmatz JS; Mertzanis P; Graf JA; Durol AL; Counihan M; Roth-Schechter B; Shader RI
Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Nguyen MH; Yu CY
J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
[TBL] [Abstract][Full Text] [Related]
16. Liver injury associated with ketoconazole: review of the published evidence.
Greenblatt HK; Greenblatt DJ
J Clin Pharmacol; 2014 Dec; 54(12):1321-9. PubMed ID: 25216238
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.
Gupta AK; Kohli Y; Li A; Faergemann J; Summerbell RC
Br J Dermatol; 2000 Apr; 142(4):758-65. PubMed ID: 10792228
[TBL] [Abstract][Full Text] [Related]
18. Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
Warrilow AG; Price CL; Parker JE; Rolley NJ; Smyrniotis CJ; Hughes DD; Thoss V; Nes WD; Kelly DE; Holman TR; Kelly SL
Sci Rep; 2016 Jun; 6():27690. PubMed ID: 27291783
[TBL] [Abstract][Full Text] [Related]
19. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole.
Liu X; Zhang Y; Chen Q; Zhan Y; Wang Q; Hu C; Yu C; Guo Z; Chen X; Zhong D
J Clin Pharmacol; 2018 Mar; 58(3):347-356. PubMed ID: 28967981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
